perfluoropentane has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afridi, I; Franco, F; Grayburn, PA; Hundley, WG; Kizilbash, AM; Peshock, RM | 2 |
2 trial(s) available for perfluoropentane and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Echocardiography; Female; Fluorocarbons; Heart Ventricles; Humans; Image Enhancement; Infusions, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Reproducibility of Results; Stroke Volume; Ventricular Dysfunction, Left | 1998 |
Effect of contrast enhancement on transthoracic echocardiographic assessment of left ventricular regional wall motion.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Echocardiography; Female; Fluorocarbons; Heart Ventricles; Humans; Infusions, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Observer Variation; Prospective Studies; Reproducibility of Results; Ventricular Dysfunction, Left | 1999 |